No abstract

No abstract

No abstract

A numerical model with a memory effect was created to describe the kinetics of 10B in blood after a single 4-dihydroxyborylphenylalanine-fructose complex (BPA-F) infusion in boron neutron capture therapy (BNCT). The model formulation was based on the averaged data from 10 glioma patients from the Brookhaven National Laboratory (BNL) BNCT-trials. These patients received a 2 h i.v. infusion of a BPA-fructose complex that delivered 290 mg BPA/kg body weight. The model was validated by fitting the original BNL patient data and new patient data from the Finnish BNCT-trials. The new 3-parameter non-linear model provided mean absolute differences between the measured and estimated 10B concentrations in blood that were less than 3.9% when used to simulate actual patient irradiations that comprised two irradiation fields separated by a break to reposition the patient. The flexibility of the model was successfully tested with two different infusion protocols. The patient data were modelled with a two-compartment model and a bi-exponential fit for comparison. The 3-parameter model is better than previously described models in predicting the time course of blood 10B concentration after cessation of intravenous infusion of BPA-fructose.

The first neutron Fourier diffractometer at the pulsed neutron source, the High Resolution Fourier Diffractometer (HRFD), is described. The HRFD combines both high neutron flux at the sample position, -107n/cm2/s, provided by the IBR-2 high flux pulsed reactor, and high resolution, very close to 0.001, over a wide range of d-spacings. The paper deals with the basic principles of HRFD, its design, and performance. Examples of structural experiments are also given.